tag:blogger.com,1999:blog-33686001544638869002009-11-07T12:43:39.857+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.comBlogger127125blogspot/uDWThttp://feedburner.google.comtag:blogger.com,1999:blog-3368600154463886900.post-41648545894842899842009-11-05T12:54:00.000+05:302009-11-05T12:54:49.600+05:302009-11-05T12:54:49.600+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial Esposito K, Maiorino MI, Ciotola M, et al Ann Intern Med. 2009;151:306-314 Study Summary <p><a href="http://feedads.g.doubleclick.net/~a/D3fV8_R96XhnFQKsDLVICrlr-8k/0/da"><img src="http://feedads.g.doubleclick.net/~a/D3fV8_R96XhnFQKsDLVICrlr-8k/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/D3fV8_R96XhnFQKsDLVICrlr-8k/1/da"><img src="http://feedads.g.doubleclick.net/~a/D3fV8_R96XhnFQKsDLVICrlr-8k/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/bxtZ63yR1Lc" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/11/mediterranean-diet-delays-need-for-drug.htmltag:blogger.com,1999:blog-3368600154463886900.post-60630779959113786182009-10-30T21:01:00.001+05:302009-10-30T21:01:44.907+05:302009-10-30T21:01:44.907+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0The latest ATP III guidelines now recommend that LDL cholesterol levels be brought below 100 mg/dL in high-risk and moderate risk patients and that consideration should be given to lowering it to < 70 mg/dL in high risk individuals. To assess your cardiac risk see http://heartdisease.about.com/od/assessyourrisk/a/assessrisk.htm . <p><a href="http://feedads.g.doubleclick.net/~a/VzqDfIRQ5yS0H8vYKw3foJMKULQ/0/da"><img src="http://feedads.g.doubleclick.net/~a/VzqDfIRQ5yS0H8vYKw3foJMKULQ/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/VzqDfIRQ5yS0H8vYKw3foJMKULQ/1/da"><img src="http://feedads.g.doubleclick.net/~a/VzqDfIRQ5yS0H8vYKw3foJMKULQ/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/bdYeaLR1kGQ" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/10/ldl-cholesterol-levels.htmltag:blogger.com,1999:blog-3368600154463886900.post-27151390304075221702009-09-25T11:56:00.001+05:302009-09-25T11:56:50.753+05:302009-09-25T11:56:50.753+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Desperately Needed: An Education OverhaulPosted using ShareThis <p><a href="http://feedads.g.doubleclick.net/~a/COOdCB--ZaANXWM95O09veMG6Gk/0/da"><img src="http://feedads.g.doubleclick.net/~a/COOdCB--ZaANXWM95O09veMG6Gk/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/COOdCB--ZaANXWM95O09veMG6Gk/1/da"><img src="http://feedads.g.doubleclick.net/~a/COOdCB--ZaANXWM95O09veMG6Gk/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/eXa4RJoN7XI" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/09/desperately-needed-education-overhaul.htmltag:blogger.com,1999:blog-3368600154463886900.post-55461834111621689012009-09-16T22:28:00.000+05:302009-09-16T22:28:56.188+05:302009-09-16T22:28:56.188+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com01) The FDA has approved Oral-lyn, an insulin spray treatment for type I and type II diabetes, for its Investigational New Drug program. The spray delivers prandial insulin orally through a device similar to an asthma inhaler, which sprays it on the inside of the cheek, rather than via injection. Researchers have spent much time looking for alternative means of dispensing insulin to diabetics, <p><a href="http://feedads.g.doubleclick.net/~a/7GCFKzj1XJvUc8RiRXa1O4CUyNc/0/da"><img src="http://feedads.g.doubleclick.net/~a/7GCFKzj1XJvUc8RiRXa1O4CUyNc/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/7GCFKzj1XJvUc8RiRXa1O4CUyNc/1/da"><img src="http://feedads.g.doubleclick.net/~a/7GCFKzj1XJvUc8RiRXa1O4CUyNc/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/uuGL4VH7moA" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/09/oral-insulin.htmltag:blogger.com,1999:blog-3368600154463886900.post-160697754194052532009-09-09T07:44:00.002+05:302009-09-16T22:50:54.852+05:302009-09-16T22:50:54.852+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Mediterranean Diet Lets Diabetics Cut Back on Drugs - ABC News <p><a href="http://feedads.g.doubleclick.net/~a/-j28UWcK3akFWsU3PPJ7BhN-x0Y/0/da"><img src="http://feedads.g.doubleclick.net/~a/-j28UWcK3akFWsU3PPJ7BhN-x0Y/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/-j28UWcK3akFWsU3PPJ7BhN-x0Y/1/da"><img src="http://feedads.g.doubleclick.net/~a/-j28UWcK3akFWsU3PPJ7BhN-x0Y/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/E1dGyghYbNQ" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/09/mediterranean-diet-lets-diabetics-cut.htmltag:blogger.com,1999:blog-3368600154463886900.post-71688064261771988632009-09-05T06:19:00.001+05:302009-09-16T22:59:29.631+05:302009-09-16T22:59:29.631+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0 http://www.mentalhealthamerica.net/go/information/get-info/depression/depression-in-teens Source: mentalhealthamerica.net   <p><a href="http://feedads.g.doubleclick.net/~a/F7GXNYzapM2HI8RP-xMhFDxuPRY/0/da"><img src="http://feedads.g.doubleclick.net/~a/F7GXNYzapM2HI8RP-xMhFDxuPRY/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/F7GXNYzapM2HI8RP-xMhFDxuPRY/1/da"><img src="http://feedads.g.doubleclick.net/~a/F7GXNYzapM2HI8RP-xMhFDxuPRY/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/Yte-zfoSdUY" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/09/mtariqsalmangmailcom-has-shared.htmltag:blogger.com,1999:blog-3368600154463886900.post-78214001129805368282009-09-05T06:06:00.002+05:302009-09-16T23:03:50.557+05:302009-09-16T23:03:50.557+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Check out this link for detailed information on Drugs.com: http://www.drugs.com/news/fruit-even-healthier-than-thought-study-19704.html The website is http://www.drugs.com/, which has a database of over 24,000 drugs, plus a Drug Interactions checker and a pictorial Pill Identifier. <p><a href="http://feedads.g.doubleclick.net/~a/BkiLQHUb5-JFWl-IKQiGzWF_quw/0/da"><img src="http://feedads.g.doubleclick.net/~a/BkiLQHUb5-JFWl-IKQiGzWF_quw/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/BkiLQHUb5-JFWl-IKQiGzWF_quw/1/da"><img src="http://feedads.g.doubleclick.net/~a/BkiLQHUb5-JFWl-IKQiGzWF_quw/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/sdoO36eHYFw" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/09/found-this-info-at-drugscom.htmltag:blogger.com,1999:blog-3368600154463886900.post-91570845357214744012009-09-03T14:20:00.001+05:302009-09-03T14:20:22.226+05:302009-09-03T14:20:22.226+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0 A link to the following article was sent to you by: Mohd Tariq Salman Antisense Molecule Shows Promise in Duchenne Muscular Dystrophy Medscape Medical News , 2009-08-26 <p><a href="http://feedads.g.doubleclick.net/~a/QAK7nDku_xgllaxMWfBRAPswiuU/0/da"><img src="http://feedads.g.doubleclick.net/~a/QAK7nDku_xgllaxMWfBRAPswiuU/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/QAK7nDku_xgllaxMWfBRAPswiuU/1/da"><img src="http://feedads.g.doubleclick.net/~a/QAK7nDku_xgllaxMWfBRAPswiuU/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/xdQpGoaMXFc" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/09/medscape-antisense-molecule-shows.htmltag:blogger.com,1999:blog-3368600154463886900.post-91993017969423674952009-08-29T10:41:00.001+05:302009-08-29T10:41:07.514+05:302009-08-29T10:41:07.514+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0mediconet.blogspot.com is a web directory which guides you to find outwebsites related with all medical needs, like journals,lectures, ebooks,videos,images,references,forums,medical advice...etc.E BOOKSPG ENTRANCEMCQSVIDEOSUSMLEREFERENCECLINICAL SKILLSOFTWARESMEDIASUGGEST A SITEwww.medicalppt. blogspot. com  contains more than thousandPresentations and lecture notes in most fields of medicine.If <p><a href="http://feedads.g.doubleclick.net/~a/bs-IFr-ESK5OkCcFCZyXd4JwdxY/0/da"><img src="http://feedads.g.doubleclick.net/~a/bs-IFr-ESK5OkCcFCZyXd4JwdxY/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/bs-IFr-ESK5OkCcFCZyXd4JwdxY/1/da"><img src="http://feedads.g.doubleclick.net/~a/bs-IFr-ESK5OkCcFCZyXd4JwdxY/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/c6U7aXzL7R0" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/useful-medical-websites.htmltag:blogger.com,1999:blog-3368600154463886900.post-17826557431546984572009-08-18T17:27:00.001+05:302009-08-18T17:27:15.811+05:302009-08-18T17:27:15.811+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0 <!-- ADX: Begin TopRight-EmailThis --&gt; <!-- ADX: End TopRight-EmailThis --&gt; <!-- BEGING MESSAGE SENT BY ... --&gt; This page was sent to you by:  mtariqsalman@gmail.com SCIENCE   | August 18, 2009 Tests Begin on Drugs That May Slow Aging By NICHOLAS WADE Excitement among some researchers has picked up with the apparent convergence of <p><a href="http://feedads.g.doubleclick.net/~a/N9mxnyjSIzY2vsH-I3oBycJy17o/0/da"><img src="http://feedads.g.doubleclick.net/~a/N9mxnyjSIzY2vsH-I3oBycJy17o/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/N9mxnyjSIzY2vsH-I3oBycJy17o/1/da"><img src="http://feedads.g.doubleclick.net/~a/N9mxnyjSIzY2vsH-I3oBycJy17o/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/DZqwjSh31HI" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/nytimescom-tests-begin-on-drugs-that.htmltag:blogger.com,1999:blog-3368600154463886900.post-28225110190973558742009-08-18T17:26:00.001+05:302009-08-18T17:26:41.936+05:302009-08-18T17:26:41.936+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0---------- Forwarded message ----------From: Drugs.com <sender@list.drugs.com&gt;Date: 2009/8/18Subject: US FDA Approves Extavia - the First in a New Portfolio ofPlanned MS Therapies from Novartis to Help Patients with ThisDevastating DiseaseTo: mtariqsalman@gmail.comSent to you from Drugs.comNew Drug ApprovalUS FDA Approves Extavia - the First in a New Portfolio of Planned MSTherapies from Novartis <p><a href="http://feedads.g.doubleclick.net/~a/6zQh6IfXNPdtmmWNmDM6egL4gKk/0/da"><img src="http://feedads.g.doubleclick.net/~a/6zQh6IfXNPdtmmWNmDM6egL4gKk/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/6zQh6IfXNPdtmmWNmDM6egL4gKk/1/da"><img src="http://feedads.g.doubleclick.net/~a/6zQh6IfXNPdtmmWNmDM6egL4gKk/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/w1UHY-XgZgk" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/fwd-us-fda-approves-extavia-first-in.htmltag:blogger.com,1999:blog-3368600154463886900.post-21018656945449883682009-08-14T07:51:00.006+05:302009-08-14T08:20:06.535+05:302009-08-14T08:20:06.535+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0 Many researchers believe tumour growth is driven by cancerous stem cells that, for reasons not yet understood, are highly resistant to standard treatments. Chemotherapeutic agents may kill off 99 percent of the cells in a tumor, but the stem cells that remain can make the cancer recur or spread to other tissues in the body to cause new cancers. Stem cells, unlike mature cells, can constantly <p><a href="http://feedads.g.doubleclick.net/~a/gmPBJ301Fju6CbRvFUQ0yfCHd38/0/da"><img src="http://feedads.g.doubleclick.net/~a/gmPBJ301Fju6CbRvFUQ0yfCHd38/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/gmPBJ301Fju6CbRvFUQ0yfCHd38/1/da"><img src="http://feedads.g.doubleclick.net/~a/gmPBJ301Fju6CbRvFUQ0yfCHd38/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/25inNZ-Dfa8" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/new-screening-method-for-anticancer.htmltag:blogger.com,1999:blog-3368600154463886900.post-51979587833137713892009-08-11T21:17:00.001+05:302009-08-11T21:20:19.876+05:302009-08-11T21:20:19.876+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com1LacosamideLacosamide is an amino acid-related compound that has been studied in both pain syndromes and partial seizures.Mechanism of Action: Lacosamide enhances slow inactivation of voltage-gated Na+ channels. It also binds to the collapsin-response mediator protein, CRMP-2, thereby blocking the effect of neurotrophic factors such as BDNF and NT3 on axonal and dendritic growth. <p><a href="http://feedads.g.doubleclick.net/~a/MjuZaUjYIo4wh8C_n3z18Lwmy10/0/da"><img src="http://feedads.g.doubleclick.net/~a/MjuZaUjYIo4wh8C_n3z18Lwmy10/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/MjuZaUjYIo4wh8C_n3z18Lwmy10/1/da"><img src="http://feedads.g.doubleclick.net/~a/MjuZaUjYIo4wh8C_n3z18Lwmy10/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/LZMOPyhlDQY" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/newer-drugs-for-epilepsy.htmltag:blogger.com,1999:blog-3368600154463886900.post-13475113287313938482009-08-06T07:45:00.008+05:302009-08-06T08:49:00.019+05:302009-08-06T08:49:00.019+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com4Authors: Dr Syed Ziaur Rahman, MD, Dr Mohd Tariq Salman, MDPublisher: Ibn Sina Academy of Medieval Medicine and Sciences1st Edition: 2009, ISBN 978-81-906070-8-7We teach animal experimentation in all science disciplines. However, since it is now not possible to sacrifice and demonstrate the effects of drugs on animals in large numbers due to ethical considerations; we in medical colleges in India <p><a href="http://feedads.g.doubleclick.net/~a/GkKb7gB435mEz2x_ewyQ706HjMA/0/da"><img src="http://feedads.g.doubleclick.net/~a/GkKb7gB435mEz2x_ewyQ706HjMA/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/GkKb7gB435mEz2x_ewyQ706HjMA/1/da"><img src="http://feedads.g.doubleclick.net/~a/GkKb7gB435mEz2x_ewyQ706HjMA/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/ksE5yhyMDPw" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/guide-to-alternatives-to-animal.htmltag:blogger.com,1999:blog-3368600154463886900.post-18398444865748442822009-08-06T07:45:00.003+05:302009-08-06T08:00:05.511+05:302009-08-06T08:00:05.511+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0The GCP HelpDesk is a support service provided to respond to queries raised by Investigators/Physicians on Good Clinical Practice in Clinical Research. It provides a central point of contact on global GCP issues and ensures that consistent replies are provided to questions. The HelpDesk also allows the users to give their feedback, which will be continuously reviewed in order to improve its <p><a href="http://feedads.g.doubleclick.net/~a/I-0klR1gkpy78k3tyXpoj6EfAV8/0/da"><img src="http://feedads.g.doubleclick.net/~a/I-0klR1gkpy78k3tyXpoj6EfAV8/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/I-0klR1gkpy78k3tyXpoj6EfAV8/1/da"><img src="http://feedads.g.doubleclick.net/~a/I-0klR1gkpy78k3tyXpoj6EfAV8/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/LsO1KW8Fx7I" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/08/good-clinical-practices-helpdesk.htmltag:blogger.com,1999:blog-3368600154463886900.post-68854536211166559632009-07-16T07:55:00.003+05:302009-07-16T08:01:56.290+05:302009-07-16T08:01:56.290+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com1In a prospective, randomized trial, a single daily tablet containing efavirenz, emtricitabine, and tenofovir (Atripla; Bristol Myers Squibb & Gilead Sciences LLC) maintained viral suppression in HIV-1 infected patients as well as the standard multiple-pill regimen. The report of the study, published in the Journal of the Acquired Immune Deficiency Syndrome, notes that at <p><a href="http://feedads.g.doubleclick.net/~a/m9ErPGePBO2wps8eQSM5Frl-MJ0/0/da"><img src="http://feedads.g.doubleclick.net/~a/m9ErPGePBO2wps8eQSM5Frl-MJ0/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/m9ErPGePBO2wps8eQSM5Frl-MJ0/1/da"><img src="http://feedads.g.doubleclick.net/~a/m9ErPGePBO2wps8eQSM5Frl-MJ0/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/FpSMQ7XfAXA" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/07/single-daily-poly-pill-for-hiv.htmltag:blogger.com,1999:blog-3368600154463886900.post-48413585876225990082009-07-13T10:18:00.004+05:302009-07-13T10:36:21.134+05:302009-07-13T10:36:21.134+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com1For teachers who are net-savvy, want to be on the cuttiong edge of new teaching methodologies and collaborative learning and are enthisiastic about developing their teaching skills in a new and dramatic way, this blog gines a description of Web 2.0 websites and webtools which have potential for use college and university teaching.http://web20teach.blogspot.com/ <p><a href="http://feedads.g.doubleclick.net/~a/F4oukTJE3qRIumYmKCo0_hi8yt4/0/da"><img src="http://feedads.g.doubleclick.net/~a/F4oukTJE3qRIumYmKCo0_hi8yt4/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/F4oukTJE3qRIumYmKCo0_hi8yt4/1/da"><img src="http://feedads.g.doubleclick.net/~a/F4oukTJE3qRIumYmKCo0_hi8yt4/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/hLd_xUy0EnA" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/07/web-20-tools-for-teaching.htmltag:blogger.com,1999:blog-3368600154463886900.post-55321228702779456642009-07-05T11:00:00.005+05:302009-07-05T11:12:53.347+05:302009-07-05T11:12:53.347+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Ceftobiprole is the first member of a new series of advanced cephalosporins with activity against methicillin-resistant Staphylococcus aureus (MRSA). The drug received a letter of approval from the United States Food and Drug Administration (FDA) in March 2008 for the treatment of complicated skin and skin structure infections including diabetic foot infections. Ceftobiprole exerts its <p><a href="http://feedads.g.doubleclick.net/~a/5gjkwU9WCk75k_GNFF8E2d2XuhE/0/da"><img src="http://feedads.g.doubleclick.net/~a/5gjkwU9WCk75k_GNFF8E2d2XuhE/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/5gjkwU9WCk75k_GNFF8E2d2XuhE/1/da"><img src="http://feedads.g.doubleclick.net/~a/5gjkwU9WCk75k_GNFF8E2d2XuhE/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/UL7k4BHT9_o" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/07/ceftobiprole-first-cephalosporin-with.htmltag:blogger.com,1999:blog-3368600154463886900.post-64572699867303394802009-06-27T08:04:00.004+05:302009-06-27T08:12:51.583+05:302009-06-27T08:12:51.583+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0The following two sites give updated and detailed description of all known Receptors and ion Channels.:1) IUPHAR Database of G Protein-Coupled Receptors and the IUPHAR Database of Voltage-Gated and Ligand-Gated Ion Channels.2) Guide to Receptors and Channels (GRAC), 3rd edition published by British Pharmacological society. <p><a href="http://feedads.g.doubleclick.net/~a/rEs0L277Vz1u2lsdrar521hnlgc/0/da"><img src="http://feedads.g.doubleclick.net/~a/rEs0L277Vz1u2lsdrar521hnlgc/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/rEs0L277Vz1u2lsdrar521hnlgc/1/da"><img src="http://feedads.g.doubleclick.net/~a/rEs0L277Vz1u2lsdrar521hnlgc/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/dpZBC28Tod4" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/06/database-of-receptors-and-channels.htmltag:blogger.com,1999:blog-3368600154463886900.post-38814493576469112952009-06-20T14:45:00.003+05:302009-06-29T22:10:33.799+05:302009-06-29T22:10:33.799+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0A Study of Nigella sativa Linn. seeds for antimicrobial activity against multidrug resistant clinical strains of Pseudomonas aeruginosa.Authors: Mohd T Salman(1),*, Rahat A Khan(1), Indu Shukla(2)Address: (1)Department of Pharmacology, (2)Department of Microbiology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India. 202002.*Corresponding Author: Present address- <p><a href="http://feedads.g.doubleclick.net/~a/dpNz_pI455bdD7_UkfQ0X-Q53LQ/0/da"><img src="http://feedads.g.doubleclick.net/~a/dpNz_pI455bdD7_UkfQ0X-Q53LQ/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/dpNz_pI455bdD7_UkfQ0X-Q53LQ/1/da"><img src="http://feedads.g.doubleclick.net/~a/dpNz_pI455bdD7_UkfQ0X-Q53LQ/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/LBMjtc2OJg4" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/06/study-of-nigella-sativa-linn-seeds-for.htmltag:blogger.com,1999:blog-3368600154463886900.post-78898457049531363332009-06-17T21:33:00.001+05:302009-06-17T21:37:53.149+05:302009-06-17T21:37:53.149+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0 Published Online First: 15 December 2008. doi:10.1136/sti.2008.032334 Sexually Transmitted Infections 2009;85:116-120 Copyright © 2009 by the BMJ Publishing Group Ltd. <!--/slugline--&gt; <p><a href="http://feedads.g.doubleclick.net/~a/9Dlkmr5_fU2a5R_NdjPvRlvXtiU/0/da"><img src="http://feedads.g.doubleclick.net/~a/9Dlkmr5_fU2a5R_NdjPvRlvXtiU/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/9Dlkmr5_fU2a5R_NdjPvRlvXtiU/1/da"><img src="http://feedads.g.doubleclick.net/~a/9Dlkmr5_fU2a5R_NdjPvRlvXtiU/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/CozP8tKfD7I" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/06/circumcision.htmltag:blogger.com,1999:blog-3368600154463886900.post-54638340201513173862009-06-14T07:46:00.003+05:302009-06-14T07:54:03.896+05:302009-06-14T07:54:03.896+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com1SimponiPharmacological class: TNF blocker.Active Ingredient: Golimumab 50mg/0.5mL; soln for SC inj; preservative-free.Indication: Moderately to severely active rheumatoid arthritis (RA), in combination with methotrexate (MTX). Active psoriatic arthritis (PsA), alone or with MTX. Active ankylosing spondylitis (AS).Company: Centocor Ortho Biotech, Inc.Axert approved for migraine treatment in <p><a href="http://feedads.g.doubleclick.net/~a/qsf24Ren7qbrwWdQikWVfXnx2bs/0/da"><img src="http://feedads.g.doubleclick.net/~a/qsf24Ren7qbrwWdQikWVfXnx2bs/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/qsf24Ren7qbrwWdQikWVfXnx2bs/1/da"><img src="http://feedads.g.doubleclick.net/~a/qsf24Ren7qbrwWdQikWVfXnx2bs/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/-FXl16WmM7w" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/06/some-new-drug-approvals-in-june-2009.htmltag:blogger.com,1999:blog-3368600154463886900.post-9404135530803039992009-06-14T06:48:00.002+05:302009-06-14T06:56:16.781+05:302009-06-14T06:56:16.781+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0The U.S. FDA approved Cycloset, a new quick-release oral formulation of bromocriptine mesylateis, which is the first therapy directly targeting the body’s dopamine activity to improve glycemic control. It is also the only drug to be approved subsequent to the FDA's guidelines that require studies demonstrating that diabetes drugs do not increase cardiovascular risk. Preclinical studies <p><a href="http://feedads.g.doubleclick.net/~a/utB0oc4PD_59i12qnC0eAcwuqhs/0/da"><img src="http://feedads.g.doubleclick.net/~a/utB0oc4PD_59i12qnC0eAcwuqhs/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/utB0oc4PD_59i12qnC0eAcwuqhs/1/da"><img src="http://feedads.g.doubleclick.net/~a/utB0oc4PD_59i12qnC0eAcwuqhs/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/B37KKvcAw_E" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/06/cycloset-new-antidiabetic.htmltag:blogger.com,1999:blog-3368600154463886900.post-31934916718215564962009-06-13T21:48:00.002+05:302009-06-13T21:58:36.706+05:302009-06-13T21:58:36.706+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Several chemical entities that affect the DNA methylation landscape of the genome are now being used. The earliest of these, 5-azacytidine and azacytidine, are chemical analogs of the nucleoside cytidine and its deoxy derivative, decitabine. Through incorporation into DNA (during replication) and RNA (during transcription), they inhibit methyltransferases and thereby cause demethylation of the <p><a href="http://feedads.g.doubleclick.net/~a/sscK9wHQADZPw-3QGxMBx4-it3E/0/da"><img src="http://feedads.g.doubleclick.net/~a/sscK9wHQADZPw-3QGxMBx4-it3E/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/sscK9wHQADZPw-3QGxMBx4-it3E/1/da"><img src="http://feedads.g.doubleclick.net/~a/sscK9wHQADZPw-3QGxMBx4-it3E/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/zUF87KZWIVs" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/06/drugs-modifying-epigenetic-status.htmltag:blogger.com,1999:blog-3368600154463886900.post-15630630864522908442009-05-23T20:00:00.002+05:302009-05-23T20:07:19.750+05:302009-05-23T20:07:19.750+05:30Dr Mohd Tariq Salmanhttp://www.blogger.com/profile/18072398752683879869noreply@blogger.com0Although theoretically 3rd generation beta blockers such as nebivolol are supposed to be more advantagious over cardioselective ones due to their additional vasodilating property because of action on alpha receptors, Randomized Controlled trials have failed to show their additional benefits. Since s-metoprolol has more benefits compared to r isomer, it can be predicted that it would be <p><a href="http://feedads.g.doubleclick.net/~a/Q02_efW_20-xYrOeQOvQMElr0-I/0/da"><img src="http://feedads.g.doubleclick.net/~a/Q02_efW_20-xYrOeQOvQMElr0-I/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/Q02_efW_20-xYrOeQOvQMElr0-I/1/da"><img src="http://feedads.g.doubleclick.net/~a/Q02_efW_20-xYrOeQOvQMElr0-I/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/blogspot/uDWT/~4/m0FUzvI0mb8" height="1" width="1"/>http://medicalresearch.blogspot.com/2009/05/s-metoprolol-for-hypertension-and-heart.html